Clinical impact of the use of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers

Lung Cancer ◽  
2011 ◽  
Vol 74 (2) ◽  
pp. 244-247 ◽  
Author(s):  
Gustavo Lyons ◽  
Silvia Quadrelli ◽  
Pablo Jordan ◽  
Henri Colt ◽  
Domingo Chimondeguy
Keyword(s):  
Lung Cancer ◽  
International Association ◽  
Staging System ◽  
Cancer Staging ◽  
Small Cell ◽  
Clinical Impact ◽  
Small Cell Lung ◽  
Lung Cancers

scholarly journals Applicability of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers☆

2009 ◽  
Vol 36 (6) ◽  
pp. 1031-1036 ◽  
Author(s):  
Makoto Suzuki ◽  
Shigetoshi Yoshida ◽  
Hajime Tamura ◽  
Hironobu Wada ◽  
Yasumitsu Moriya ◽  
...  
Keyword(s):  
Lung Cancer ◽  
International Association ◽  
Staging System ◽  
Cancer Staging ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancers

Lung Cancer: Staging

Chest Imaging ◽  
2019 ◽  
pp. 281-287
Author(s):  
Ryo E. C. Benson
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Mediastinal Lymph Node ◽  
Tnm Classification ◽  
Cancer Staging ◽  
Tnm Staging ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancers ◽  
Resected Tumor

Lung cancer staging is a process used to assess the extent of spread of lung cancer, determine the most appropriate treatment and predict the patient’s prognosis. Clinical staging is performed prior to surgical resection, while surgical-pathologic staging is based on histologic analysis of the resected tumor and lymph nodes. Restaging is performed following treatment. Staging is based on the TNM classification system. T refers to the primary tumor, N to thoracic lymph node involvement and M to metastatic disease. Recent changes to T and M descriptors were made to better reflect actual survival. For the majority of non-small cell lung cancers, the presence or absence of mediastinal lymph node spread is the most important outcome predictor. Although no changes were made to the N descriptor, the actual intrathoracic lymph node stations were recently clarified. Although the majority of small cell lung cancers are metastatic at the time of presentation, the presence of limited versus extensive spread of disease determines treatment options. However, the overall prognosis and survival for affected patients is poor. TNM staging is now recommended for carcinoid tumors as well as small cell lung cancer.

scholarly journals Fate of Pneumonectomy Patients Variably Captured by Non-Small Cell Lung Cancer Staging System

2017 ◽  
Vol 104 (6) ◽  
pp. 1829-1836 ◽  
Author(s):  
Andrew P. Dhanasopon ◽  
Michelle C. Salazar ◽  
Jessica R. Hoag ◽  
Joshua E. Rosen ◽  
Anthony W. Kim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Staging System ◽  
Cancer Staging ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document